Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines

Published:2020-05 Issue:6 Volume:80 Page:527-544
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Shore Neal D.¹^ORCID,Antonarakis Emmanuel S.²^ORCID,Cookson Michael S.³,Crawford E. David⁴,Morgans Alicia K.⁵,Albala David M.⁶,Hafron Jason⁷⁸⁹,Harris Richard G.¹⁰,Saltzstein Daniel¹¹,Brown Gordon A.¹²¹³,Henderson Jonathan¹⁴,Lowentritt Benjamin¹⁵,Spier Jeffrey M.¹⁶,Concepcion Raoul¹⁷¹⁸

Affiliation:

1. Carolina Urologic Research Center, Atlantic Urology Clinics Myrtle Beach South Carolina

2. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland

3. Department of UrologyUniversity of Oklahoma Oklahoma City Oklahoma

4. University of California, San Diego LaJolla California

5. Northwestern University, Robert H. Lurie Comprehensive Cancer Center Chicago Illinois

6. Crouse Hospital Syracuse New York

7. Willam Beaumont School of Medicine, Oakland University Rochester Michigan

8. Beaumont Health Royal Oak Michigan

9. Michigan Institute of Urology Troy Michigan

10. Uropartners Melrose Park Illinois

11. Urology San Antonio San Antonio Texas

12. Rowan‐School of Medicine Stratford New Jersey

13. Jefferson Health New Jersey, New Jersey Urology Sewell New Jersey

14. Regional Urology, LLC Shreveport Louisiana

15. Chesapeake Urology Associates in Maryland Chesapeake Maryland

16. Rio Grande Urology El Paso Texas

17. Integra Connect West Palm Beach Florida

18. Department of UrologyVanderbilt University School of Medicine Nashville Tennessee

Funder

LUGPA Unrestricted Grant From Tolmar Pharmaceuticals

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23967

Reference97 articles.

1. Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

2. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States

3. Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer

4. Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

5. Fifteen-Year Survival Outcomes Following Primary Androgen-Deprivation Therapy for Localized Prostate Cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer;Pharmacological Reports;2023-11-03

2. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer;New England Journal of Medicine;2023-10-19

3. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification;Prostate Cancer and Prostatic Diseases;2023-09-07

4. The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma;Journal of Clinical Medicine;2023-08-22

5. Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development;Biomedicines;2023-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3